LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Botox and Myobloc Linked to Hospitalizations and Death
Feb-8-08 Rockville, MD The US Food and Drug Administration (FDA) today notified the public that Botox and Botox Cosmetic (botulinum toxin Type A), and Myobloc (botulinum toxin Type B) have been linked to adverse reactions, including respiratory failure and death. The reactions reported are suggestive of botulism, which occurs when botulinum toxin spreads in... - Customers Sue Countrywide Financial for Unfair Pricing
Feb-8-08 Los Angeles, CA: Two couples in California are suing Countrywide Financial Corp. , a home and mortgage lender, because they claim the company made agreements with appraisers to try and beat the sinking housing market by inflating the prices paid for homes. Filed in Los Angeles Superior court on Wednesday, the complaint also names KB Home Mortgage Co... - Accutane: Depression, Suicide and Degenerative Diseases
Feb-7-08 Chicago, IL The tendency of some patients to become depressed and to exhibit suicidal behavior while taking Accutane (isotretinoin), is once again in the limelight. Friday, former Chicago Bull's cheerleader Kim Smith filed a lawsuit against Hoffmann-La Roche, the manufacturer of Accutane, in which she claims Accutane left her in a dark depression... - Public Health Advisory Issued by FDA on Chantix
Feb-7-08 Rockville, MD: A Public-Health Advisory has been issued by the US Food and Drug Administration to caregivers, health care providers, and patients regarding new warnings that concern the stop smoking prescription medication, Chantix . An Early Communication was issued to health care providers and the public by the FDA on November 20, 2007, regarding the... - FDA Estimates Approximately 83,000 Heart Attacks caused by Avandia
Feb-7-08 Rockville, MD: A report released by the Senate Finance Committee in November 2007, stated that an analysis conducted by the FDA that was presented at the safety panel meeting on July 30, 2007 says that approximately 83,000 people suffered heart attacks as a result of taking Avandia. The report that is called, "The Intimidation of Dr. John Buse and the D... - Power Plant Pollution, Mirant Bowline Inc. agrees to $300,000 air and water violations settlement
Albany, NY: (Feb-4-08) The New York State Department of Environmental Conservation (DEC) brought charges against Mirant Bowline Inc., claiming that the company had alleged air and water violations at its West Haverstraw (Rockland County) power plant. The suit claimed that the DEC found several violations centered on malfunctioning monitoring equipment. In... - Schering-Plough: Dragging Heels on Vytorin Study, a Breach of ERISA?
Feb-5-08 Kenilworth, NJ The long-awaited, and long-delayed release of the ENHANCE study on the effects and efficacy of the cholesterol drug Vytorin (Zocor combined with Zetia) may have done more than raise the ire of doctors and the medical community: it also may have ticked off investors of Schering-Plough , one of the two manufacturers involved in Vytorin. The... - Wachovia 401(k) Investors: Who's Watching Out for You?
Feb-4-08 Charlotte, NC: You could forgive yourself for putting your trust—and your money—into an institution that suggests it's gonna 'watch-over-ya.' How can it not, with a name like Wachovia ? However, the opposite could be true as investors are watching Wachovia take a hit from the nation's credit crisis, and almost certain corresponding losses in... - Trasylol Fiasco - FDA Fails To Protect Americans Again - Part II
Feb-4-08 Washington, DC: In reading the report issued by the Zuckerman Spaeder law firm, one thing is perfectly clear. Bayer was willing to pay $700,000 to get a Trasylol study done in time for the September 21, 2006 advisory committee meeting, if it could refute the findings of the New England Journal of Medicine study. However, unbeknownst to the contract re... - Suicides by Chantix Users Prompt FDA Advisory
Feb-3-08 Rockville, MD: Serious neuropsychiatric symptoms have occurred in patients taking Chantix (Varenicline). These symptoms include changes in behavior, agitation, depressed mood, suicidal ideation, and attempted and completed suicide , according to a Public Health Advisory issued February 1, 2008 by the U.S. Food and Drug Administration (FDA). The FDA i... - Avandia Drug Company GlaxoSmithKline gets a Helping Hand it Didn't Deserve
Feb-3-08 San Antonio TX: Avandia's manufacturer, GlaxoSmithKline, got an unfair helping hand while many diabetics just got sicker. The diabetes drug Avandia has been linked to heart attacks and other serious physical ailments. But recently, the drug maker got a shot in its own arm when it received advance notice of a peer-review article that was then-to be publ... - imbee Data Collection, Industrious Kid, Inc. pays $130,000 civil penalty for violating the Children's Online Privacy Protection Act
New York, NY: (Jan-31-08) The US Federal Trade Commission (FTC) brought charges against Industrious Kid, Inc., and owner Jeanette Symons, the operators of imbee.com, a social networking site specifically targeting kids and tweens, alleging that their data-collection practices violated federal law. The suit claimed that the imbee.com web site was promoted a... - Zetia/Vytorin: What Did They Know and When Did They Know It?
Feb-3-08 Kenilworth, NJ: The scandal over Merck/Schering-Plough's long delay in releasing the results of the ENHANCE tests of its big-bucks anti-cholesterol medication Vytorin continues to grow—to the extent that The Wall Street Journal now calls it "Vytoringate". And like its predecessor scandal, the focus of investigations has come down to a simple question: Wh... - Bank of America: Income Down 95%, 401k Plans Down?
Feb-2-08 Charlotte, NC: Bank of America is yet another victim of the slowing US economy and the damaging sub-prime mortgage crisis, prompting the company to undertake a multi-billion-dollar debt write down. Worse, the less-then-stellar performance may have put Bank of America retirement fund investors at risk for reduced Bank of America 401k portfolios, alleging... - Zetia Raises Heart Attack Risks
Feb-2-08 Whitehouse Station, NJ: The Food and Drug Administration (FDA) said, on Friday (Jan 25, 2008), that they will review the safety and efficacy of Zetia /Zocor (Vytorin) after results from the ENHANCE trial suggested that the combination had no significant reduction in atherosclerotic-plaque progression. Steven Nissen, M.D., director of cardiovascular med... - Trasylol Fiasco - FDA Fails To Protect Americans Again - Part I
Feb-1-08 Washington, DC: On November 5, 2007, the FDA announced that Bayer Pharmaceuticals had suspended the marketing of Trasylol after preliminary results of a Canadian study indicated that patients may also have a greater risk of death than patients taking either of two other drugs. The Canadian study, Blood Antifibrinolytics Randomized Trial (BART), led... - Breach of Contract, EPCOR Power pays NAL Resources a $4.2 million settlement regarding a natural gas supply agreement
Edmonton, CA: (Jan-28-08) NAL Resources Ltd. brought a lawsuit against EPCOR Power LP, alleging breach of contract. The suit stated that NAL Resources, a subsidiary of Manulife Financial Corporation, supplied natural gas to EPCOR Power's Tunis power plant located in Ontario, and that EPCOR violated terms with respect to Tunis natural gas supply contracts... - Trasylol: The Worm Turned Almost Overnight
Jan-27-08 Long Island, NY: By now most are familiar with the recent fortunes of anti-bleeding drug Trasylol , and how it has been pulled from world markets after studies have revealed links to heart attack, stroke and kidney failure . A major Canadian study was halted back in October after concern over the death rate of aprotinin (Trasylol) participants. The US Fo... - Zetia/Vytorin Manufacturers Pull TV Ads
Jan-24-08 Kenilworth, NJ: Merck/Schering-Plough announced on Tuesday January 22, that they are pulling all direct-to-consumer (DTC) television advertisements for their Zetia and Vytorin products. Zetia is Merck/Schering's branded anti-cholesterol drug which is also used in Vytorin, which contains Zetia and the statin drug Zocor (simvastation). Merck/Schering's... - Light Rail Contract, Metro pays Cross County Collaborative $6 million breach of contract settlement
St. Louis, MO: (Jan-22-08) Cross County Collaborative (CCC) brought a lawsuit against Metro, seeking to recover $28 million in legal fees and other costs spent in Metro's litigation involving the MetroLink extension project from Forest Park to Shrewsbury. Sources stated that the suit stemmed from Metro pursuing an $81 million award in alleged damages from...